Search research articles
Contact Us
Filters
Showing results (21-30 of 43) with videos related to
Page
of 5
Sort By:
Nature Reviews. Urology
|
September 16, 2021
Neoadjuvant hormonal therapy before radical prostatectomy in high-risk prostate cancer
Gaëtan Devos, Wout Devlies, Gert De Meerleer, et al.
Urology
|
April 26, 2024
Nutritional Supplement With Fermented Soy in Men With an Elevated Risk of Prostate Cancer and Negative Prostate Biopsies: General and Oncological Results From the Prospective PRAECAP Trial
Hans Van Der Eecken, Bram Vansevenant, Gaëtan Devos, et al.
Frontiers in Oncology
|
September 27, 2019
Comparison of Peri-operative and Early Oncological Outcomes of Robot-Assisted vs. Open Salvage Lymph Node Dissection in Recurrent Prostate Cancer
Gaëtan Devos, Tim Muilwijk, Yannic Raskin, et al.
World Journal of Urology
|
February 13, 2021
Neoadjuvant treatment with androgen receptor signaling inhibitors prior to radical prostatectomy: a systematic review
Gaëtan Devos, Bram Vansevenant, Gert De Meerleer, et al.
Urologic Oncology
|
November 16, 2019
Development and external validation of a nomogram to predict lymph node invasion after robot assisted radical prostatectomy
Lorenzo Tosco, Gaëtan Devos, Greet De Coster, et al.
Cancers
|
August 23, 2020
Oncological Outcomes of Metastasis-Directed Therapy in Oligorecurrent Prostate Cancer Patients Following Radical Prostatectomy
Gaëtan Devos, Charlien Berghen, Henri Van Eecke, et al.
World Journal of Urology
|
May 18, 2020
Site-specific relapse patterns of patients with biochemical recurrence following radical prostatectomy assessed by <sup>68</sup>Ga-PSMA-11 PET/CT or <sup>11</sup>C-Choline PET/CT: impact of postoperative treatments
Gaëtan Devos, Manuel Witters, Lisa Moris, et al.
Expert Review of Anticancer Therapy
|
November 23, 2020
Current and emerging therapies for localized high-risk prostate cancer
Lisa Moris, Gaëtan Devos, Thomas Van den Broeck, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
September 13, 2024
Comparison of PSMA immunohistochemistry scoring systems to parametric [<sup>18</sup>F]PSMA-1007 PET/MRI in primary prostate cancer
Niloefar Ahmadi Bidakhvidi, Thomas Gevaert, Maxim De Schepper, et al.
World Journal of Urology
|
March 13, 2019
Metastasectomy for visceral and skeletal oligorecurrent prostate cancer
Antonino Battaglia, Gaëtan Devos, Karel Decaestecker, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 43) with videos related to
Sort By:
Page
of 5
Nature Reviews. Urology
|
September 16, 2021
Neoadjuvant hormonal therapy before radical prostatectomy in high-risk prostate cancer
Gaëtan Devos, Wout Devlies, Gert De Meerleer, et al.
Urology
|
April 26, 2024
Nutritional Supplement With Fermented Soy in Men With an Elevated Risk of Prostate Cancer and Negative Prostate Biopsies: General and Oncological Results From the Prospective PRAECAP Trial
Hans Van Der Eecken, Bram Vansevenant, Gaëtan Devos, et al.
Frontiers in Oncology
|
September 27, 2019
Comparison of Peri-operative and Early Oncological Outcomes of Robot-Assisted vs. Open Salvage Lymph Node Dissection in Recurrent Prostate Cancer
Gaëtan Devos, Tim Muilwijk, Yannic Raskin, et al.
World Journal of Urology
|
February 13, 2021
Neoadjuvant treatment with androgen receptor signaling inhibitors prior to radical prostatectomy: a systematic review
Gaëtan Devos, Bram Vansevenant, Gert De Meerleer, et al.
Urologic Oncology
|
November 16, 2019
Development and external validation of a nomogram to predict lymph node invasion after robot assisted radical prostatectomy
Lorenzo Tosco, Gaëtan Devos, Greet De Coster, et al.
Cancers
|
August 23, 2020
Oncological Outcomes of Metastasis-Directed Therapy in Oligorecurrent Prostate Cancer Patients Following Radical Prostatectomy
Gaëtan Devos, Charlien Berghen, Henri Van Eecke, et al.
World Journal of Urology
|
May 18, 2020
Site-specific relapse patterns of patients with biochemical recurrence following radical prostatectomy assessed by <sup>68</sup>Ga-PSMA-11 PET/CT or <sup>11</sup>C-Choline PET/CT: impact of postoperative treatments
Gaëtan Devos, Manuel Witters, Lisa Moris, et al.
Expert Review of Anticancer Therapy
|
November 23, 2020
Current and emerging therapies for localized high-risk prostate cancer
Lisa Moris, Gaëtan Devos, Thomas Van den Broeck, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
September 13, 2024
Comparison of PSMA immunohistochemistry scoring systems to parametric [<sup>18</sup>F]PSMA-1007 PET/MRI in primary prostate cancer
Niloefar Ahmadi Bidakhvidi, Thomas Gevaert, Maxim De Schepper, et al.
World Journal of Urology
|
March 13, 2019
Metastasectomy for visceral and skeletal oligorecurrent prostate cancer
Antonino Battaglia, Gaëtan Devos, Karel Decaestecker, et al.
Page
of 5